Cited by

• A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes.

  Coudeville L, Andre P, Bailleux F, Weber F, Plotkin S. Coudeville L, et al. Hum Vaccin. 2010 Oct;6(10):841-8. doi: 10.4161/hv.6.10.12636. Epub 2010 Oct 1. Hum Vaccin. 2010. PMID: 20930559 Free PMC article.
• Behaviour and control of influenza in institutions and small societies.

  Finnie TJ, Hall IM, Leach S. Finnie TJ, et al. J R Soc Med. 2012 Feb;105(2):66-73. doi: 10.1258/jrsm.2012.110249. J R Soc Med. 2012. PMID: 22357982 Free PMC article. Review.
• Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic.

  Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, Baker MG, Beasley R, Reid S, Roberts S, Hope V; 2009 H1N1 Serosurvey Investigation Team. Bandaranayake D, et al. PLoS One. 2010 Oct 14;5(10):e13211. doi: 10.1371/journal.pone.0013211. PLoS One. 2010. PMID: 20976224 Free PMC article.
• Infection with influenza A/Victoria virus in Houston families, 1976.

  Taber LH, Paredes A, Glezen WP, Couch RB. Taber LH, et al. J Hyg (Lond). 1981 Jun;86(3):303-13. doi: 10.1017/s0022172400069059. J Hyg (Lond). 1981. PMID: 7016989 Free PMC article.
• Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.

  Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, Yano T, Suga T, Kawakami C, Yamamoto M, Kajiyama K, Saito H, Shimada S, Watanabe S, Aoki S, Taira K, Kon M, Lin JH, Odagiri T. Kishida N, et al. Clin Vaccine Immunol. 2012 Jun;19(6):897-908. doi: 10.1128/CVI.05726-11. Epub 2012 Apr 4. Clin Vaccine Immunol. 2012. PMID: 22492743 Free PMC article.